Recombinant Opitutus terrae Protoheme IX farnesyltransferase (ctaB)

What is Protoheme IX farnesyltransferase (ctaB) and what is its biochemical function?

Protoheme IX farnesyltransferase (ctaB) is a membrane protein that plays a crucial role in bacterial respiratory pathways. This enzyme catalyzes the conversion of heme B (protoheme IX) to heme O by substituting the vinyl group on carbon 2 of the heme B porphyrin ring with a hydroxyethyl farnesyl side group . This reaction represents a critical step in the biosynthesis of terminal oxidases required for bacterial respiration.

The protein is also known by alternative names including Heme B farnesyltransferase and Heme O synthase . It belongs to the enzyme classification EC 2.5.1.-, indicating its role as a transferase that forms carbon-carbon bonds .

Methodologically, researchers can assess ctaB activity through spectrophotometric assays that monitor the consumption of substrate (heme B) and formation of product (heme O), typically using HPLC separation followed by spectral analysis of the characteristic absorbance profiles of these heme derivatives.

What is known about the organism Opitutus terrae and how does this context inform ctaB research?

Opitutus terrae is a bacterium with the following characteristics:

• Cells are cocci (spherical) and motile via flagellum

• Lacks catalase and oxidase activities

• Growth is supported by mono-, di-, and polysaccharides, but not by alcohols, amino acids, or organic acids

• Major fermentation end-products include propionate and acetate

• Can reduce nitrate to nitrite

• Genomic DNA has a high G+C content of 74 mol%

The organism belongs to the phylum Verrucomicrobia and was initially isolated from rice paddy soil, representing a relatively under-studied bacterial group. Understanding the biochemical and physiological context of Opitutus terrae provides important insights for ctaB research, particularly regarding adaptations to anaerobic or microaerobic environments where heme-based respiratory systems may play specialized roles.

When designing experiments with recombinant Opitutus terrae ctaB, researchers should consider the native conditions of the source organism, including pH, temperature, and redox environment that may affect protein folding and activity.

What expression systems are most effective for producing recombinant Opitutus terrae ctaB?

Multiple expression systems have been successfully used to produce recombinant Opitutus terrae ctaB, each with distinct advantages for different research applications:

For recombinant ctaB production, researchers should consider using codon-optimized constructs, especially when expressing in heterologous systems, to improve translation efficiency . Expression typically employs vectors containing affinity tags (N-terminal or C-terminal) to facilitate purification, though tag selection should be carefully considered as it may affect protein activity or solubility .

What analytical approaches are recommended for characterizing ctaB enzymatic activity and substrate specificity?

Characterizing the enzymatic activity and substrate specificity of Protoheme IX farnesyltransferase requires specialized techniques due to the hydrophobic nature of both the enzyme and its substrates/products.

Recommended analytical approaches include:

• In vitro enzyme assays: Using purified recombinant ctaB with heme B as substrate and detecting heme O formation. This typically requires:

  • Detergent solubilization of the enzyme (common detergents include DDM, LMNG, or digitonin)

  • Incorporation of a farnesyl diphosphate (FPP) donor

  • Anaerobic conditions to prevent heme oxidation

  • Monitoring by HPLC with UV-vis detection (characteristic absorption at 400-410 nm)

• Substrate analog studies: Testing modified heme structures to determine specificity:

• Kinetic analysis: Determining enzyme parameters (Km, Vmax, kcat) through initial velocity measurements under varying substrate concentrations, typically analyzed using Michaelis-Menten or Lineweaver-Burk plots.

• Inhibitor studies: Using competitive and non-competitive inhibitors to characterize the enzyme active site and reaction mechanism.

For researchers new to this field, beginning with coupled enzyme assays that produce a more easily detectable signal (such as fluorescence or colorimetric change) may provide a more accessible entry point before transitioning to more complex direct assays.

How can researchers effectively study the impact of ctaB mutations on respiratory chain function?

Studying the impact of ctaB mutations on respiratory chain function requires a multi-faceted approach that combines genetic, biochemical, and physiological methods:

• Site-directed mutagenesis strategy:

  • Target conserved residues identified through multiple sequence alignment

  • Focus on predicted active site residues and membrane-interfacing regions

  • Create a library of point mutations, especially targeting residues corresponding to those known to be functionally important in homologous proteins

• Functional respiratory chain assessment:

  • Oxygen consumption measurements using Clark-type electrodes or optode systems

  • Membrane potential determination using fluorescent dyes (e.g., DiSC3(5) or JC-1)

  • Electron transfer activity measurement between respiratory complexes using artificial electron acceptors

• Specific terminal oxidase activity assays:

  • Spectroscopic analysis of cytochrome c oxidation

  • NADH oxidation rates in membrane preparations

  • Specific inhibitor studies to distinguish between different terminal oxidases

• In vivo phenotypic characterization:

  • Growth under varying oxygen tensions

  • Survival under oxidative stress conditions

  • Metabolic profiling under aerobic vs. anaerobic conditions

When designing mutation studies, researchers should incorporate the following table of commonly targeted mutation types and their potential impacts:

What are the methodological considerations for studying ctaB's role in bacterial persister cell formation?

The link between ctaB function and bacterial persister cell formation, particularly as observed in S. aureus , presents an intriguing area for research. Persister cells are phenotypic variants that exhibit tolerance to antibiotics without genetic resistance, and effective study of ctaB's role requires careful experimental design.

Key methodological considerations include:

• Persister cell isolation and quantification:

  • Time-kill assays with suprainhibitory antibiotic concentrations

  • Biphasic killing curves analysis to distinguish persisters from resistant mutants

  • CFU counting on antibiotic-free media after antibiotic exposure

  • Single-cell microscopy with viability staining to directly observe persisters

• Genetic approaches:

  • Construction of ctaB conditional expression strains (using inducible promoters)

  • Complementation with wild-type and mutant versions of ctaB

  • Transcriptional reporter fusions to monitor ctaB expression during persister formation

• Metabolic analysis of persister state:

  • ATP measurements in persister-enriched populations

  • Membrane potential assessment in single cells

  • Respiration rate determination using oxygen-sensitive probes

  • Metabolomic profiling of persister vs. non-persister populations

• Transcriptional regulation studies:

  • ChIP-seq to identify regulators binding to the ctaB promoter

  • RNA-seq comparing wild-type and ctaB mutant strains under persister-inducing conditions

  • qRT-PCR validation of key differentially expressed genes

When designing persister studies, researchers should be aware of the high variability inherent in persister assays and implement appropriate controls and statistical analyses. Using multiple antibiotics with different mechanisms of action can help distinguish general persister phenotypes from specific effects related to particular antibiotic classes.

How do structural and functional properties of ctaB compare across different bacterial species?

Comparative analysis of ctaB across bacterial species provides valuable insights into evolutionary conservation and functional adaptation. While the core catalytic function—converting heme B to heme O through farnesylation—is preserved, significant variations exist in structural features and regulatory contexts.

Based on available data, the following comparative analysis can be assembled:

*Note: Some values are approximate based on homologous proteins as exact data for all species was not available in the provided search results.

When studying ctaB across species, researchers should consider:

• Sequence homology analysis:

  • Multiple sequence alignment to identify conserved motifs

  • Phylogenetic analysis to understand evolutionary relationships

  • Identification of species-specific insertions or deletions

• Heterologous expression studies:

  • Cross-complementation experiments (e.g., expressing Opitutus terrae ctaB in S. aureus ctaB mutant)

  • Activity assays under standardized conditions to compare catalytic parameters

  • Structural studies to correlate sequence differences with functional variations

• Ecological context consideration:

  • Analysis of ctaB adaptation to different environmental niches

  • Correlation of structural variations with oxygen availability in natural habitat

  • Examination of co-evolution with other respiratory chain components

This comparative approach not only enhances fundamental understanding of ctaB function but also provides insights into potential biotechnological applications and targeted inhibitor development.

What are the emerging research directions for ctaB studies?

Current evidence suggests several promising research directions for ctaB studies:

• Antimicrobial development: The link between ctaB function and bacterial virulence suggests that inhibitors of this enzyme might represent a novel class of antivirulence compounds that could reduce pathogenicity without directly killing bacteria, potentially reducing selective pressure for resistance development.

• Synthetic biology applications: Engineering ctaB variants with altered substrate specificity could enable production of novel heme derivatives with potential applications in biosensors or biocatalysis.

• Systems biology integration: Positioning ctaB within global metabolic networks through multi-omics approaches could reveal unexpected connections between heme metabolism and other cellular processes.

• Structural biology advancements: Application of emerging techniques like cryo-EM to membrane proteins may overcome historical challenges in obtaining high-resolution structures of ctaB and related enzymes.

• Evolutionary analysis: Deeper investigation of ctaB distribution across bacterial phyla could provide insights into the evolution of respiratory chains and adaptation to varying oxygen environments.